Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.55 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.55 |
| ▸ | KIF20B | Q96Q89 | 2/20 | 0.43 |
| ▸ | PTPN1 | P18031 | 4/20 | 0.42 |
| ▸ | ALOX5 | P09917 | 4/20 | 0.41 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.41 |
| ▸ | PTGS2 | P35354 | 4/20 | 0.40 |
| ▸ | PTGES | O14684 | 2/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | RECQL | P46063 | 1/20 | 0.37 |
| ▸ | BLM | P54132 | 1/20 | 0.37 |
| ▸ | CENPE | Q02224 | 1/20 | 0.37 |
| ▸ | ESR1 | P03372 | 1/20 | 0.36 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.36 |
| ▸ | TOP2A | P11388 | 1/20 | 0.34 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29661466 | 1.00 | TDP1 (0.55) | TDP1L3MBTL1KIF20BPTPN1ALOX5 | |
| SCHEMBL22860829 | 0.84 | TDP1 (0.49) | TDP1L3MBTL1KIF20BPTPN1ALOX5 | |
| SCHEMBL22860845 | 0.83 | TDP1 (0.69) | TDP1L3MBTL1KIF20BPTPN1ALOX5 | |
| SCHEMBL9151323 | 0.82 | TDP1 (0.67) | TDP1L3MBTL1KIF20BPTPN1ALOX5 | |
| SCHEMBL22860858 | 0.76 | TDP1 (0.51) | TDP1L3MBTL1KIF20BPTPN1ALOX5 | |
| SCHEMBL29661452 | 0.76 | TDP1 (0.51) | TDP1L3MBTL1KIF20BPTPN1ALOX5 | |
| SCHEMBL29661653 | 0.73 | L3MBTL1 (0.39) | TDP1L3MBTL1PTPN1ALOX5PTGS2 | |
| SCHEMBL22860893 | 0.73 | L3MBTL1 (0.39) | TDP1L3MBTL1PTPN1ALOX5PTGS2 | |
| SCHEMBL22905115 | 0.72 | CNR2 (0.52) | TDP1L3MBTL1 | |
| SCHEMBL22860885 | 0.69 | CNR2 (0.38) | TDP1L3MBTL1KIF20BPTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230024212-A1 | CANNABINOID DERIVATIVES | JGB COLLATERAL LLC | 2023-01-26 | — | — | US | disclosed |
| WO-2021113959-A1 | CANNABINOID DERIVATIVES | CANOPY GROWTH CORPORATION (CA) | 2021-06-17 | — | — | WO | disclosed |
| WO-2021000054-A1 | CANNABINOID DERIVATIVES | CANOPY GROWTH CORPORATION (CA) | 2021-01-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230024212-A1 | CANNABINOID DERIVATIVES | CNR2, GPR18, CNR1 | TDP1 4531/4885L3MBTL1 4726/4885KIF20B 1919/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.